cascade

Diclofenac (Diclofenacum) is a nonsteroidal benzeneacetic acid derivative with anti-inflammatory activity. Diclofenac binds and chelates both isoforms of cyclooxygenase (COX-1 and-2), thereby blocking the conversion of arachidonic acid to pro-inflammatory-proprostaglandins.

Diclofenac Diethylamine, a non-selective COX inhibitor, is utilized as a nonsteroidal anti-inflammatory drug (NSAID).

Diclofenac sodium (GP 45840) is a non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.

Diclofenac Potassium (CGP-45840B) is a nonsteroidal anti-inflammatory drug taken to reduce inflammation and as an analgesic reducing pain in certain conditions.

Flufenoxuron（Cascade）is a benzoylurea pesticide that inhibits chitin synthesis in insects. Flufenoxuron is toxic and suppresses the proliferation of testicular cells by targeting mitochondria in mice.

3,6-Dihydroxyflavone suppresses the epithelial-mesenchymal transition in breast cancer cells by inhibiting the Notch signaling pathway.

RSK2-IN-3 (Compound 26) is a covalent, reversible inhibitor of the RPS6KA3 (RSK2) kinase.

Melagatran is an orally available, direct synthetic thrombin inhibitor that does not require endogenous cofactors other than thrombin and does not significantly interact with any other enzymes in the coagulation cascade or with the fibrinolytic enzymes.

Milvexian (BMS-986177/JNJ-70033093) is an orally bioavailable, small-molecule, reversible, and direct antagonist of Factor XIa (FXIa). It exhibits potent inhibitory activity across species, with Ki values of 0.11 nM for human, 0.38 nM for rabbit, and 0.64 nM for dog. By targeting FXIa, Milvexian selectively inhibits the intrinsic pathway of the coagulation cascade. It demonstrates robust antithrombotic efficacy in various in vitro and in vivo models while maintaining a favorable safety profile regarding bleeding risk. It is a critical tool for investigating novel anticoagulant strategies in thrombosis and cardiovascular research.

SF5 is an inhibitor of the apoptosis pathway. Which is through the JNK-p53-caspase apoptotic cascade.

Monensin is an orally active natural antibiotic that also functions as an ion carrier mediating Na+/H+ exchange and a Wnt inhibitor, effective against Gram-positive bacteria, Plasmodium falciparum, and certain viruses.

Jasmonic acid (JA) is a phytohormone and plant growth regulator involved in plant defense and growth and development.Jasmonic acid plays an important role in signaling, inducing the MAP kinase cascade pathway and calcium channels.

TAC (TERT activator compound) is a TERT (telomerase reverse transcriptase) activator that enhances TERT transcriptional activity through the MEK/ERK/AP-1 cascade pathway, promotes telomere synthesis in primary human cells and naturally aged mice, reduces cellular senescence and inflammatory cytokines, and alleviates neuroinflammation, among other effects.

Microtubule destabilizing agent-2 (Compound 21) is an orally active and selective anticancer compound targeting microtubule proteins. It disrupts microtubule stability, inhibiting microtubule polymerization. This agent causes human tumor cells to arrest in the G0/G1 phase and induces apoptosis (Apoptosis) through activation of the Caspase cascade pathway. Additionally, it exhibits anti-inflammatory properties, inhibiting the production of TNF-α and IL-6 in vitro. Microtubule destabilizing agent-2 also suppresses tumor growth in xenograft mice.

Tubulin-IN-52 is a potent, selective tubulin polymerization inhibitor with an IC₅₀ of 2.9 μM. Tubulin-IN-52 induces apoptosis in tumor cells by triggering a caspase cascade via the mitochondrial apoptosis pathway. Tubulin-IN-52 significantly inhibits tumor growth without significant toxicity. Tubulin-IN-52 can be used in cancer-related research.

WMJ-J-09 is a novel hydroxamate-based HDAC inhibitor that induces tumor cell apoptosis by activating the LKB1-AMPK signaling cascade and downregulating Survivin.

Donidalorsen is an antisense oligonucleotide engineered to selectively reduce the production of prekallikrein (PKK), a key upstream mediator in inflammatory cascade activation, and is used in hereditary angioedema research to investigate bradykinin-driven inflammation, acute attack prevention mechanisms, and RNA-targeted therapeutic strategies.

RAS activator compound 1 is an effective small GTPase modulator and Ras-GTP signaling pathway activator. It sustainably enhances kinase cascade signaling by directly binding and stabilizing the active conformation of Ras with its effectors, commonly used to investigate Ras-driven hyperproliferation and oncogenesis.

GTPL547 is a potent quorum sensing system antagonist specifically targeting the PqsR (MvfR) transcriptional regulator in Pseudomonas aeruginosa (IC50 = 12 nM). By halting the PQS-mediated gene transcription cascade, it completely suppresses the secretion of lethal virulence factors like pyocyanin and the irreversible assembly of biofilms, providing a critical lead compound for tackling multidrug-resistant infections.

3-(4-Octadecylbenzoyl)acrylic acid is an effective broad-spectrum phospholipase A2 (PLA2) inhibitor. By preventing the release of arachidonic acid from membrane phospholipids, it severs the biosynthetic cascade of prostaglandins and leukotrienes, demonstrating exceptionally potent anti-inflammatory activity in acute inflammation and tissue injury models.

ER-464195-01 is an orally active inhibitor that targets the interaction between CRT and ITGAs. By disrupting the binding of CRT and ITGAs, ER-464195-01 reduces leukocyte infiltration and subsequent inflammatory cascade reactions. It downregulates the expression of pro-inflammatory genes induced by DSS, such as [TNF-α], [IL-1β], [IL-6], [IL-17f], and inhibits the phosphorylation of STAT3 and the production of serum amyloid A (SAA). This compound is applicable for research in inflammatory bowel disease (IBD).

TopoisomeraseI-IN-18, a derivative of Thiosemicarbazide, functions as a Topoisomerase I inhibitor, disrupting DNA synthesis and transcription. It suppresses tumor cell proliferation by inducing S phase cell cycle arrest. Additionally, it enhances mitochondria-mediated apoptosis (apoptosis), evidenced by inhibited cell migration and increased intracellular reactive oxygen species (ROS). TopoisomeraseI-IN-18 upregulates p53 protein expression, γH2AX phosphorylation, Bax expression, downregulates Bcl-2 expression, and activates the caspase cascade. This compound is applicable for lung cancer research.

KRAS G12D-IN-30 (Compound 4) is a KRAS inhibitor. It functions by blocking the activity of the KRAS G12 mutant, thereby inhibiting the activation of downstream MAPK signaling cascade regulators (Raf1-MEK-ERK). KRAS G12D-IN-30 is applicable for cancer research.

SKF-96365 hydrochloride (SKF96365) , a SOCE inhibitor, exhibits potent anti-neoplastic activity by inducing cell-cycle arrest and apoptosis in colorectal Y cells. SKF-96365 hydrochloride can induce cytoprotective autophagy to delay apoptosis by preventing the release of cytochrome c (cyt c) from the mitochondria into the cytoplasm. Mechanistically, SKF-96365 hydrochloride treatment inhibited the calcium/calmodulin-dependent protein kinase IIγ (CaMKIIγ)/AKT signaling cascade in vitro and in vivo. Overexpression of CaMKIIγ or AKT abolished the effects of SKF-96365 on Y cells, suggesting a critical role of the CaMKIIγ/AKT signaling pathway in SFK-96365-induced biological effects. SKF-96365 hydrochloride inhibited hERG current in a concentration-dependent manner.